BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17211056)

  • 1. [Akathisia in the course of olanzapine treatment].
    Makkos Z; Csonka A
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):215-7. PubMed ID: 17211056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripirazole-olanzapine combination for treatment of schizophrenia.
    Duggal HS
    Can J Psychiatry; 2004 Feb; 49(2):151. PubMed ID: 15065751
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe akathisia during olanzapine treatment of acute schizophrenia.
    Jauss M; Schröder J; Pantel J; Bachmann S; Gerdsen I; Mundt C
    Pharmacopsychiatry; 1998 Jul; 31(4):146-8. PubMed ID: 9754850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of akathisia after switching from branded to generic high-dose olanzapine.
    Goldberg JF
    J Clin Psychiatry; 2012 Apr; 73(4):497. PubMed ID: 22579148
    [No Abstract]   [Full Text] [Related]  

  • 5. Periodic limb movement disorder in neuroleptic-induced akathisia.
    Nishimatsu O; Horiguchi J; Inami Y; Sukegawa T; Sasaki A
    Kobe J Med Sci; 1997 Oct; 43(5):169-77. PubMed ID: 9642972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidences of extrapyramidal symptoms in patients with schizophrenia after treatment with long-acting injection (depot) or oral formulations of olanzapine.
    Hill AL; Sun B; McDonnell DP
    Clin Schizophr Relat Psychoses; 2014 Jan; 7(4):216-22. PubMed ID: 23428782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
    Vieta E; Panicali F; Goetz I; Reed C; Comes M; Tohen M;
    J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.
    Chen CH; Huang MC; Lu ML
    J Clin Psychopharmacol; 2007 Oct; 27(5):516-7. PubMed ID: 17873689
    [No Abstract]   [Full Text] [Related]  

  • 9. Atypical antipsychotic-induced akathisia with depression: therapeutic role of mirtazapine.
    Ranjan S; Chandra PS; Chaturvedi SK; Prabhu SC; Gupta A
    Ann Pharmacother; 2006 Apr; 40(4):771-4. PubMed ID: 16569791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Olanzapine as an alternative in clozapine-induced akathisia?].
    Knoch H; Hofmann M; Seifritz E
    Psychiatr Prax; 1999 Nov; 26(6):308. PubMed ID: 10627963
    [No Abstract]   [Full Text] [Related]  

  • 11. Aggression, agitation, and mania with olanzapine.
    John V; Rapp M; Pies R
    Can J Psychiatry; 1998 Dec; 43(10):1054. PubMed ID: 9868577
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse events related to olanzapine.
    Conley RR; Meltzer HY
    J Clin Psychiatry; 2000; 61 Suppl 8():26-9; discussion 30. PubMed ID: 10811240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine-induced triglyceride and aminotransferase elevations without weight gain or hyperglycemia normalized after switching to aripiprazole.
    Pawelczyk T; Pawelczyk A; Rabe-Jablonska J
    J Psychiatr Pract; 2014 Jul; 20(4):301-7. PubMed ID: 25036587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodological concerns in a trial of ziprasidone and olanzapine.
    Carnahan RM; Perry PJ
    Am J Psychiatry; 2005 Jul; 162(7):1391; author reply 1391-2. PubMed ID: 15994736
    [No Abstract]   [Full Text] [Related]  

  • 15. [Optimizing the antipsychotic potency of olanzapine by augmentation--a critical review].
    Zink M
    Psychiatr Prax; 2006 Sep; 33(6):261-8. PubMed ID: 16929455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosing the antipsychotic medication olanzapine.
    Nemeroff CB
    J Clin Psychiatry; 1997; 58 Suppl 10():45-9. PubMed ID: 9265916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine vs haloperidol for treatment of schizophrenia.
    de Haan L; van Beveren N
    JAMA; 2004 Mar; 291(9):1065; author reply 1065-6. PubMed ID: 14996769
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of olanzapine.
    Beasley CM; Tollefson GD; Tran PV
    J Clin Psychiatry; 1997; 58 Suppl 10():13-7. PubMed ID: 9265911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine vs haloperidol for treatment of schizophrenia.
    Glazer WM
    JAMA; 2004 Mar; 291(9):1064-5; author reply 1065-6. PubMed ID: 14996766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.